Jane Street Group, LLC Anavex Life Sciences Corp. Put Options Transaction History

Jane Street Group, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 17, 2022	SELL	$9.74 - $17.69 $164,606 - $298,961	-16,900 Reduced 12.0%	123,900 $1.53 Million
Q4 2021 Feb 15, 2022	SELL	$16.88 - $23.31 $1.49 Million - $2.05 Million	-88,000 Reduced 38.46%	140,800 $2.44 Million
Q3 2021 Nov 16, 2021	SELL	$16.82 - $25.75 $1.62 Million - $2.48 Million	-96,500 Reduced 29.66%	228,800 $4.11 Million
Q2 2021 Aug 16, 2021	BUY	$10.16 - $28.86 $2.92 Million - $8.29 Million	287,200 Added 753.81%	325,300 $7.44 Million
Q1 2021 May 18, 2021	BUY	$5.17 - $16.13 $196,977 - $614,553	38,100 New	38,100 $570,000

154

27.3M

515K

838K

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $581M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.